Pitcairn’s Globus Medical GMED Stock Holding History

Pitcairn’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-8,105	Closed	-$208K	–	437
2015 Q2	$208K	Buy	+8,105	New	+$205K	0.02%	442

Other funds holding GMED

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

ORI

Oak Ridge Investments Chicago, Illinois $1.51B AUM 37.25% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

Kalmar Investments Greenville, Delaware $443M AUM 23.5% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Pitcairn's GMED Position: Q3 2015 in Review

Pitcairn sold out of Globus Medical (GMED) in Q3 2015, closing a stake of 8,105 shares — an estimated $208K sold.

Pitcairn first reported a position in GMED in Q2 2015 and held it in 1 quarter. The position peaked at $208K in Q2 2015. 182 funds tracked by Wall St. Rank hold GMED as of Q3 2015.

Pitcairn reported no remaining Globus Medical position as of Q3 2015 after selling out during the quarter.
Pitcairn sold 8,105 Globus Medical shares in Q3 2015, an estimated $208K.
Pitcairn first reported a position in Globus Medical in Q2 2015 and held it in 1 quarter.
Pitcairn's Globus Medical position peaked at $208K in Q2 2015.
182 funds tracked by Wall St. Rank held Globus Medical as of Q3 2015.

Based on Pitcairn's 13F filing for Q3 2015, filed 2 Nov 2015.